1-9 of 9
Bruno Paiva
Close
Sort by
Journal Articles

Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia

Esperanza Martin-Sanchez, Laura Blanco Fernández, Peter S. Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús F. San-Miguel, Ana Alfonso, Juan Miguel Bergua Burgues, Rebeca Rodríguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Bruno Paiva, Aintzane Zabaleta
Journal: Blood Advances
Blood Adv bloodadvances.2024013212.
https://doi.org/10.1182/bloodadvances.2024013212
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

Clinical Trials & Observations
Bruno Paiva, Anastasiia Zherniakova, Jorge M. Nuñez-Córdoba, Paula Rodriguez-Otero, Qian Shi, Nikhil C. Munshi, Brian G. M. Durie, Jesus San-Miguel
Journal: Blood Advances
Blood Adv (2023) 8 (1): 219–223.
https://doi.org/10.1182/bloodadvances.2023010821
Published: 2023
Includes: Supplemental data
Journal Articles

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

Catia Simoes, Maria-Carmen Chillon, David Martínez-Cuadrón, Maria-José Calasanz, María-Belén Vridiales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso Pierola, Felipe Prosper, Rosa Ayala, Joaquin Martínez-López, Juan Miguel Bergua Burgues, Susana Vives, Jose A. Perez-Simon, Maria Garcia-Fortes, Teresa Bernal del Castillo, Mercedes Colorado, Mayte Olave, Juan I. Rodríguez-Gutiérrez, Jorge Labrador, Marcos González, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos, Bruno Paiva
Journal: Blood Advances
Blood Adv (2023) 7 (1): 167–173.
https://doi.org/10.1182/bloodadvances.2022008141
Published: 2023
Includes: Supplemental data
Journal Articles

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquín Martínez-López, Albert Oriol, María-Jesús Blanchard, Rafael Ríos, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Verónica González-Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José-María Moraleda, Joan Bargay, María-Teresa Cedena, Bruno Paiva, Laura Rosiñol, Joan Bladé, Jesús San Miguel, Juan-José Lahuerta, María-Victoria Mateos
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3234–3239.
https://doi.org/10.1182/bloodadvances.2021006762
Published: 2022
Includes: Supplemental data
Journal Articles

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

Cirino Botta, Catarina Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, María-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo Roccaro, Hartmut Goldschmidt, Hervé Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús F. San-Miguel, Bruno Paiva,
Journal: Blood Advances
Blood Adv (2022) 6 (2): 690–703.
https://doi.org/10.1182/bloodadvances.2021005198
Published: 2022
Includes: Supplemental data
Journal Articles

Early detection of treatment failure and early rescue intervention in multiple myeloma: time for new approaches

Clinical Trials & Observations
Juan José Lahuerta, Bruno Paiva, Ana Jiménez de Ubieto, José Sánchez-Pina, María-Victoria Mateos, Joan Bladé, Jesús F. San-Miguel
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1340–1343.
https://doi.org/10.1182/bloodadvances.2020003996
Published: 2021
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data
Journal Articles

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Clinical Trials & Observations
Nikhil C. Munshi, Herve Avet-Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur, Meletios Dimopoulos, Margarita Kulakova, Annette Lam, Mahmoud Hashim, Jianming He, Bart Heeg, Jon Ukropec, Jessica Vermeulen, Sarah Cote, Nizar Bahlis
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5988–5999.
https://doi.org/10.1182/bloodadvances.2020002827
Published: 2020
Includes: Supplemental data
Journal Articles

Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT

Christine M. Ho, Philip L. McCarthy, Paul K. Wallace, Yali Zhang, Ahmad Fora, Patrick Mellors, Joseph D. Tario, Benjamin L. S. McCarthy, George L. Chen, Sarah A. Holstein, Sophia R. Balderman, Xuefang Cao, Bruno Paiva, Theresa Hahn
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1056–1066.
https://doi.org/10.1182/bloodadvances.2017005447
Published: 2017
Includes: Supplemental data